Charles Lutsch, PhD, is Associate Vice President, Global Project Head Adjuvants, Research Portfolio Strategy R&D, Sanofi-Vaccines, France.
Previously, he was heading R&D Global Health Vaccine Center of Innovation based at IDRI, Seattle, WA, USA and served as Head R&D at Shantha Biotechnics (A Sanofi Company) in Hyderabad, India.
Earlier, Charles was leading vaccines process development activities within Sanofi Pasteur USA and Sanofi Pasteur France, where he managed many facets of vaccines development in compliance with EU/FDA/WHO regulations.
He worked at Institut Pasteur and Hoffman-La-Roche and, has more than 30 years experience in the field.
He holds a PhD in Immuno-Parasitology from the Institut Pasteur and University of Lille, France.